Phase 1 Juvenile Dermatomyositis Clinical Trials

3 recruitingPhase 1

What is a Phase 1 trial?

Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.

Showing 1–3 of 3 trials

Recruiting

Phase 1Phase 2

Descartes-08 for Children, Adolescents, and Young Adults With Autoimmune Disorders

Juvenile Myasthenia GravisANCA Associated Vasculitis (AAV)Juvenile Dermatomyositis+1 more

Cartesian Therapeutics50 enrolled2 locationsNCT07089121

Recruiting

Phase 1

Clinical Study of BCMA/CD70-targeted CAR-T Therapy for Refractory Pediatric Rheumatic Diseases

Systemic Sclerosis (SSc)Polyarticular Juvenile Idiopathic ArthritisJuvenile Dermatomyositis (JDM)+1 more

Chongqing Precision Biotech Co., Ltd11 enrolled1 locationNCT07184450

Recruiting

Phase 1

Clinical Trial of CD19-targeted CAR-T Therapy for Refractory Juvenile Dermatomyositis

Juvenile Dermatomyositis

Chongqing Precision Biotech Co., Ltd10 enrolled1 locationNCT06569472